A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
2,5-Dimethoxyamphetamine
Pyrazolam
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Pyrazolam.
2,5-Dimethoxyamphetamine
Cinazepam
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Cinazepam.
2,5-Dimethoxyamphetamine
Oxazepam acetate
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Oxazepam acetate.
2,5-Dimethoxyamphetamine
Perphenazine enanthate
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Perphenazine enanthate.
2,5-Dimethoxyamphetamine
Eslicarbazepine
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Eslicarbazepine.
2,5-Dimethoxyamphetamine
Lithium carbonate
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Lithium carbonate.
2,5-Dimethoxyamphetamine
Cannabidivarin
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Cannabidivarin.
2,5-Dimethoxyamphetamine
Nordazepam
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Nordazepam.
2,5-Dimethoxyamphetamine
MRK-409
The risk or severity of adverse effects can be increased when Lasmiditan is combined with MRK-409.
2,5-Dimethoxyamphetamine
Cyclopropane
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Cyclopropane.
2,5-Dimethoxyamphetamine
Lormetazepam
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Lormetazepam.
2,5-Dimethoxyamphetamine
Clopenthixol
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Clopenthixol.
2,5-Dimethoxyamphetamine
Doxefazepam
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Doxefazepam.
2,5-Dimethoxyamphetamine
Carbromal
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Carbromal.
2,5-Dimethoxyamphetamine
Reposal
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Reposal.
2,5-Dimethoxyamphetamine
Ethadione
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Ethadione.
2,5-Dimethoxyamphetamine
Penfluridol
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Penfluridol.
2,5-Dimethoxyamphetamine
Dixyrazine
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Dixyrazine.
2,5-Dimethoxyamphetamine
Vinylbital
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Vinylbital.
2,5-Dimethoxyamphetamine
Mephenoxalone
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Mephenoxalone.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3